Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-06-29 @ 6:19 AM
Study NCT ID:
NCT03534635
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-21
First Post:
2018-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting | View |